Get startedLog in
    Picture of Co-Diagnostics logo

    CODX — Co-Diagnostics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Diagnostics Inc reports results for the quarter ended December 31 - Earnings Summary

    Picture of Co-Diagnostics logoCo-Diagnostics
    27/03/2025 21:02
    Co-Diagnostics Inc CODX.OQ reported a quarterly adjusted loss of 36 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -50 cents.  The lone analyst forecast for the quarter was for a loss of 34 cents per share.

Revenue fell 95.8% to $149.00 thousand from a year ago; analysts expected $375.00 thousand.

Co-Diagnostics Inc's reported EPS for the quarter was a loss of 36 cents​.

The company reported a quarterly loss of $11.03 million.

Co-Diagnostics Inc shares had fallen by 44.5% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "hold"

Wall Street's median 12-month price target for Co-Diagnostics Inc is $1.50

This summary was machine generated from LSEG data March 27 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)


    QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
    Dec. 31 2024-0.34-0.36Missed
    Sep. 30 2024-0.33-0.32Beat
    Jun. 30 2024-0.34-0.14Beat
    Mar. 31 2024-0.21-0.31Missed

    Recent news on Co-Diagnostics

    See all news